Biogen receives FDA approval for breakthrough ALS treatment: 'Pivotal moment in ALS research' | World & Nation

Cambridge, Massachusetts-based Biogen has gotten the green light for a breakthrough ALS treatment that targets a devastating, ultra-rare genetic form of the progressive neurodegenerative disease. The U.S. Food and Drug

Related Keywords

Massachusetts ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Jean Swidler ,Christopher Viehbacher ,Amylyx Pharmaceuticals ,Drug Administration On ,Massachusetts Based Biogen ,Drug Administration ,Ice Bucket Challenge ,Bucket Challenge ,Science And Technology ,Scientific Research ,Usiness And Commerce ,Product Research And Development ,New Products ,Da Final Approval ,Ealth And Wellness ,Medical And Pharmaceutical Regulation ,Drug And Device Approval Process ,Drug Testing And Approval Process ,Egulatory Drug Approval ,Reatments And Therapies ,Edicinal Drugs ,Rading Impact Ice Codes Important Corporate Events ,Rug And Device Regulatory Impact ,Business Operations ,Olitics And Government ,Overnment Agencies Us ,Department Of Health And Human Services ,Food And Drug Administration ,Government Regulation ,Tructured Content ,Positive Events ,North America ,Americas ,Medicine ,Ytology ,Rade ,Natomy ,Enetics ,Hysiology ,Business ,Harmacology ,